Medicines Information and the Regulation of the Promotion of Pharmaceuticals

Overview

Journal Sci Eng Ethics

Date 2018 May 4

PMID 29721844

Citations 27

Authors

Teresa Leonardo Alves

Joel Lexchin

Barbara Mintzes

Affiliations

Soon will be listed here.

Abstract

Many factors contribute to the inappropriate use of medicines, including not only a lack of information but also inaccurate and misleading promotional information. This review examines how the promotion of pharmaceuticals directly affects the prescribing and use of medicines. We define promotion broadly as all actions taken directly by pharmaceutical companies with the aim of enhancing product sales. We look in greater detail at promotion techniques aimed at prescribers, such as sales representatives, pharmaceutical advertisements in medical journals and use of key opinion leaders, along with the quality of information provided and the effects thereof. We also discuss promotion to the public, through direct-to-consumer advertising, and its effects. Finally, we consider initiatives to regulate promotion that come from industry, government and nongovernmental organizations.

Citing Articles

Evaluation of Drug and Herbal Medicinal Promotions on Social Media During the COVID-19 Pandemic in Relation to World Health Organization Ethical Criteria and South African Health Products Regulatory Authority Guidelines in South Africa:....

Chimukuche R, Ndlazi J, Mtolo L, Bird K, Seeley J Online J Public Health Inform. 2024; 16:e58378.

PMID: 39293046 PMC: 11447434. DOI: 10.2196/58378.

Pharmaceutical Drug Promotion and Rational Drug Use: Assessment of Healthcare Workers Perspective.

Akena C, Ssemanda M, Abdelaziz A, Munanura E Integr Pharm Res Pract. 2024; 13:127-138.

PMID: 39156079 PMC: 11330259. DOI: 10.2147/IPRP.S466004.

Evaluation of prescriptions from tertiary care hospitals across India for deviations from treatment guidelines & their potential consequences.

Shetty Y, Kamat S, Tripathi R, Parmar U, Jhaj R, Banerjee A Indian J Med Res. 2024; 159(2):130-141.

PMID: 38528817 PMC: 11050754. DOI: 10.4103/ijmr.ijmr_2309_22.

Marketing of medicines in primary care: An analysis of direct marketing mailings and advertisements.

Dankers M, Verlegh P, Weber K, Nelissen-Vrancken M, van Dijk L, Mantel-Teeuwisse A PLoS One. 2023; 18(8):e0290603.

PMID: 37639431 PMC: 10461816. DOI: 10.1371/journal.pone.0290603.

Pharmaceutical policies: effects of policies regulating drug marketing.

Fulone I, Cadogan C, Barberato-Filho S, Bergamaschi C, Mazzei L, Lopes L Cochrane Database Syst Rev. 2023; 6:CD013780.

PMID: 37288951 PMC: 10250001. DOI: 10.1002/14651858.CD013780.pub2.

References

Prosser H, Almond S, Walley T . Influences on GPs' decision to prescribe new drugs-the importance of who says what. Fam Pract. 2003; 20(1):61-8. DOI: 10.1093/fampra/20.1.61. View

Ziegler M, Lew P, Singer B . The accuracy of drug information from pharmaceutical sales representatives. JAMA. 1995; 273(16):1296-8. View

Grande D, Frosch D, Perkins A, Kahn B . Effect of exposure to small pharmaceutical promotional items on treatment preferences. Arch Intern Med. 2009; 169(9):887-93. DOI: 10.1001/archinternmed.2009.64. View

. Medicines Australia Code of Conduct: breaches. Aust Prescr. 2016; 38(6):216. PMC: 4674035. DOI: 10.18773/austprescr.2015.075. View

Spurling G, Mansfield P, Montgomery B, Lexchin J, Doust J, Othman N . Information from pharmaceutical companies and the quality, quantity, and cost of physicians' prescribing: a systematic review. PLoS Med. 2010; 7(10):e1000352. PMC: 2957394. DOI: 10.1371/journal.pmed.1000352. View

Alam K, Shah A, Ojha P, Palaian S, Shankar P . Evaluation of drug promotional materials in a hospital setting in Nepal. South Med Rev. 2012; 2(1):2-6. PMC: 3471165. View

Hemminki E . Content analysis of drug-detailing by pharmaceutical representatives. Med Educ. 1977; 11(3):210-5. DOI: 10.1111/j.1365-2923.1977.tb00595.x. View

Perlis R, Perlis C . Physician Payments from Industry Are Associated with Greater Medicare Part D Prescribing Costs. PLoS One. 2016; 11(5):e0155474. PMC: 4868346. DOI: 10.1371/journal.pone.0155474. View

Layton J, Kim Y, Alexander G, Emery S . Association Between Direct-to-Consumer Advertising and Testosterone Testing and Initiation in the United States, 2009-2013. JAMA. 2017; 317(11):1159-1166. PMC: 5471355. DOI: 10.1001/jama.2016.21041. View

10.

Gagnon M, Lexchin J . The cost of pushing pills: a new estimate of pharmaceutical promotion expenditures in the United States. PLoS Med. 2008; 5(1):e1. PMC: 2174966. DOI: 10.1371/journal.pmed.0050001. View

11.

Campbell E, Gruen R, Mountford J, Miller L, Cleary P, Blumenthal D . A national survey of physician-industry relationships. N Engl J Med. 2007; 356(17):1742-50. DOI: 10.1056/NEJMsa064508. View

12.

Francer J, Izquierdo J, Music T, Narsai K, Nikidis C, Simmonds H . Ethical pharmaceutical promotion and communications worldwide: codes and regulations. Philos Ethics Humanit Med. 2014; 9:7. PMC: 3974225. DOI: 10.1186/1747-5341-9-7. View

13.

Othman N, Vitry A, Roughead E . Quality of claims, references and the presentation of risk results in medical journal advertising: a comparative study in Australia, Malaysia and the United States. BMC Public Health. 2010; 10:294. PMC: 2895591. DOI: 10.1186/1471-2458-10-294. View

14.

Hansen R, Shaheen N, Schommer J . Factors influencing the shift of patients from one proton pump inhibitor to another: the effect of direct-to-consumer advertising. Clin Ther. 2005; 27(9):1478-87. DOI: 10.1016/j.clinthera.2005.09.006. View

15.

Kim H . Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters. Int J Health Policy Manag. 2015; 4(12):813-21. PMC: 4663084. DOI: 10.15171/ijhpm.2015.157. View

16.

Islam M, Farah S . Misleading promotion of drugs in Bangladesh: evidence from drug promotional brochures distributed to general practitioners by the pharmaceutical companies. J Public Health (Oxf). 2007; 29(2):212-3. DOI: 10.1093/pubmed/fdm024. View

17.

Muijrers P, Grol R, Sijbrandij J, Janknegt R, Knottnerus J . Differences in prescribing between GPs: impact of the cooperation with pharmacists and impact of visits from pharmaceutical industry representatives. Fam Pract. 2005; 22(6):624-30. DOI: 10.1093/fampra/cmi074. View

18.

Frosch D, Krueger P, Hornik R, Cronholm P, Barg F . Creating demand for prescription drugs: a content analysis of television direct-to-consumer advertising. Ann Fam Med. 2007; 5(1):6-13. PMC: 1783924. DOI: 10.1370/afm.611. View

19.

Workneh B, Gebrehiwot M, Bayo T, Gidey M, Belay Y, Tesfaye D . Influence of Medical Representatives on Prescribing Practices in Mekelle, Northern Ethiopia. PLoS One. 2016; 11(6):e0156795. PMC: 4911221. DOI: 10.1371/journal.pone.0156795. View

20.

Schwartz T, Kuhles 2nd D, Wade M, Masand P . Newly admitted psychiatric patient prescriptions and pharmaceutical sales visits. Ann Clin Psychiatry. 2002; 13(3):159-62. DOI: 10.1023/a:1012237709036. View